HSDT earnings: next report 2026-08-13, real EPS beat/miss history, analyst consensus Buy, P/E -0.05. Updated 2026-07-23.
Solana (HSDT) Research Hub
Solana (HSDT) trades on NASDAQ, US in the Healthcare (Medical - Devices) sector. As of 2026-09-11, shares last closed at 2.22 USD (+0.91%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -0.05, market cap 0.10B. This hub links to the full technical, earnings and options research available for HSDT.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Medical - Devices) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 2.22 USD (+0.91%) |
| 52-week range | 1.45 USD – 2.45 USD |
| Trend regime | Range |
| 14-day RSI | 64.8 (Bullish) |
| Trailing P/E | -0.05 |
| Market cap | 0.10B |
| Dividend yield | 0.00% |
| Next earnings | 2026-08-13 |
Available research for HSDT
Covered Call on HSDT: how it works, illustrative setup around the real 2.22 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on HSDT: how it works, illustrative setup around the real 2.22 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on HSDT: how it works, illustrative setup around the real 2.22 USD price, max profit/loss, breakeven and when to use it. Educational.
HSDT technical analysis: range, last 2.22 USD, RSI 64.8, 52w range 1.45 USD–2.45 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is HSDT in?
Solana (HSDT) is classified under Healthcare (Medical - Devices), listed on NASDAQ, US.
Is HSDT in an uptrend or downtrend?
As of 2026-09-11, HSDT is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is HSDT's trailing P/E ratio?
HSDT's trailing P/E is -0.05, with a market cap of 0.10B. See the earnings research page for full valuation detail.
When does HSDT next report earnings?
HSDT is next scheduled to report earnings on 2026-08-13, with a consensus EPS estimate of -0.02 USD.